David Swank
About David Swank
David Swank is the Technical Director of Portfolio & Asset Strategy at Bristol-Myers Squibb, with extensive experience in decision science and chemical engineering.
Current Title and Role at Bristol-Myers Squibb
David Swank serves as the Technical Director-Portfolio & Asset Strategy at Bristol-Myers Squibb. In this role, Swank provides technical consulting to other analysts within the Portfolio & Asset Strategy group. His expertise extends to decision analysis and forecasting support, with a focus on the Virology Therapeutic area since 2004.
Past Experience at GlaxoSmithKline
From 2001 to 2004, David Swank worked at GlaxoSmithKline as a Decision Scientist. During his tenure, he specialized in providing decision analysis for clinical development optimization. This role helped him hone his skills in probability of success assessment and pharmaceutical sales forecasting.
Previous Role at Rohm and Haas Co
David Swank worked as a Senior Research Process Engineer at Rohm and Haas Co for 17 years, from 1984 to 2001. In this long-standing role, Swank accumulated substantial experience in chemical engineering processes, contributing significantly to the company's research and development efforts.
Education and Chemical Engineering Expertise
David Swank holds an MS in Chemical Engineering from Clemson University, which he earned between 1982 to 1984. Additionally, he obtained a BS in Chemical Engineering from Michigan Technological University, where he studied from 1978 to 1982. These academic credentials laid a strong foundation for his career in chemical engineering and portfolio strategy.
Published Works in Pharmaceutical Sciences
David Swank co-authored the paper 'Pharmaceutical Statistics' published in 2005, which focuses on clinical development optimization. Additionally, he contributed to the paper 'Nature Reviews' published in 2011, discussing clinical development optimization. These publications underline his deep expertise in the field and his contributions to pharmaceutical research.
Specialization in Simulation and Forecasting
David Swank specializes in Monte Carlo Simulation and Clinical Trial Simulation, key techniques in the pharmaceutical industry. His professional skills also include probability of success assessment and pharmaceutical sales forecasting, making him a valuable asset in decision analysis and strategic planning at Bristol-Myers Squibb.